Bronchopulmonary dysplasia: An update

@article{Bhandari2007BronchopulmonaryDA,
  title={Bronchopulmonary dysplasia: An update},
  author={Anita Bhandari and Vineet Bhandari},
  journal={The Indian Journal of Pediatrics},
  year={2007},
  volume={74},
  pages={73-77}
}
Bronchopulmonary dysplasia (BPD) is a chronic lung disease associated with premature birth and characterized by early lung injury. Over the past 4 decades, there have been significant changes in its definition, pathology and radiological findings as well as management of BPD. Management of the acute phase and later stages of this lung disease continue to evolve. Use of non-invasive ventilatory techniques, recombinant human SOD and CC10 and inhaled NO are some novel approaches that are being… Expand
“New” Bronchopulmonary Dysplasia: A Clinical Review
New bronchopulmonary dysplasia (BPD), the most common chronic lung disease in infancy, is mostly seen in infants of <30 weeks gestational age and/or <1000 g birthweight. The lungs are characterizedExpand
Pitfalls, Problems, and Progress in Bronchopulmonary Dysplasia
TLDR
Some pitfalls, problems, and progress in bronchopulmonary dysplasia over the last decade are discussed, focusing mainly on the last 5 years, limited to studies in human neonates. Expand
Genetic Approaches to Bronchopulmonary Dysplasia.
TLDR
Research efforts have focused on investigating the gene-environment interactions that may influence an infant's susceptibility toward the development of BPD, offering hope that in the future, novel therapies will be available to ameliorate the risk for BPD. Expand
Pulmonary Biomarkers of Bronchopulmonary Dysplasia
TLDR
The physiologic role of specific biomarkers in the pulmonary tract of the human premature neonate, the perturbations that enable them to be deranged, and their proposed association with BPD are discussed. Expand
Bronchopulmonary Dysplasia/Chronic Lung Disease
TLDR
Using a physiologic definition based on an oxygen reduction challenge at 36 weeks PMA led to a 10% decrease in the incidence of Bronchopulmonary dysplasia. Expand
Prevention and Treatment of Bronchopulmonary Dysplasia: Contemporary Status and Future Outlook
TLDR
This work reviews the existing approaches to prevent and treat BPD and proposes novel and innovative therapeutic options that impact the disease on a cell/molecular level, unlike most of the current treatments available for BPD. Expand
Lung Transplantation for Bronchopulmonary Dysplasia in Adults
TLDR
Three adult patients who underwent recent lung transplantation for BPD from 2 institutions were identified and common pathologic features including hyperexpanded lungs with air trapping and mosaic attenuation on chest computed tomographic scan, severe obstructive changes on pulmonary function test, and pulmonary hypertension were shown. Expand
Postnatal Corticosteroids to Treat or Prevent Bronchopulmonary Dysplasia in Preterm Infants
TLDR
Despite the fact that early corticosteroid treatment can have beneficial outcome for BPD management through facilitation of extubation and decreasing the risk of chronic lung disease and patent ductus arteriosus, it, on the other hand, results in short-term adverse effects. Expand
The Genomics of Bronchopulmonary Dysplasia
TLDR
In this review, a critically evaluate published association studies of candidate gene polymorphisms in twins show that 53% of the variance is attributable to genetic factors. Expand
Postnatal Corticosteroids for Prevention and Treatment of Chronic Lung Disease in the Preterm Newborn
TLDR
Evaluating studies to elucidate the beneficial and harmful effects of steroid on the prevention and treatment of BPD concludes that evidence is insufficient to make a recommendation regarding other glucocorticoid doses and preparations. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 39 REFERENCES
Pathology of new bronchopulmonary dysplasia.
  • J. Coalson
  • Medicine
  • Seminars in neonatology : SN
  • 2003
TLDR
The alveolar and capillary hypoplasia of new BPD will require the development of specific therapies, but avoiding volutrauma, oxidant injury and inflammation/infection will improve lung morphology. Expand
Pathogenesis, pathology and pathophysiology of pulmonary sequelae of bronchopulmonary dysplasia in premature infants.
TLDR
The majority of the radiological findings reveal persistence of mild to moderate abnormalities long term in bronchopulmonary dysplasia, a result of dynamic processes involving inflammation, injury, repair and maturation. Expand
Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.
TLDR
Intensive therapy may modify the acute syndrome so as to permit the development of a previously unrecorded abnormality of hyaline-membrane disease. Expand
Late pulmonary sequelae of bronchopulmonary dysplasia.
TLDR
Most adolescents and young adults who had bronchopulmonary dysplasia in infancy have some degree of pulmonary dysfunction, consisting of airway obstruction, airway hyperreactivity, and hyperinflation. Expand
Pulmonary function until two years of life in infants with bronchopulmonary dysplasia.
TLDR
Although pulmonary mechanics of BPD survivors improves during the first years of life, reaching the range of normal values, at 2 yr of age they still present a substantial airway function impairment as revealed by the low forced expiratory flows. Expand
Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia.
TLDR
The amount of alveolar septal fibrosis is substantially less and tends to be more diffuse in S-BPD than in non-surfactant-treated patients; during the period after birth, there is a partial to complete arrest in acinar development (alveolar saccular andAlveolar) of similar severity for S- BPD and NS-B PD; and the comparison of RAC/MLI ratios showed similar statistically significant differences. Expand
Site-specific characteristics of infants developing bronchopulmonary dysplasia
TLDR
The analysis suggests that while some decrease in BPD can be achieved by focusing on ventilation/oxygen use, this approach is unlikely to impact on the youngest infants. Expand
Pathologic features of long-standing "healed" bronchopulmonary dysplasia: a study of 28 3- to 40-month-old infants.
Alveolar septal fibrosis, the main residual feature in the "healed" stage of bronchopulmonary dysplasia (BPD), was the consistent finding in 28 infants who died at 3 to 40 months of age, all havingExpand
Validation of the National Institutes of Health Consensus Definition of Bronchopulmonary Dysplasia
TLDR
As the severity of BPD identified by the consensus definition worsened, the incidence of those outcomes and of selected adverse neurodevelopmental outcomes increased in the infants who were seen at follow-up, and the consensus BPD definition was identified more accurately than other definitions. Expand
Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
TLDR
The benefits of late corticosteroid therapy may not outweigh actual or potential adverse effects, and there is a worrying increase in adverse neurological outcomes in infants treated with postnatal steroids. Expand
...
1
2
3
4
...